Strain-specific tumour colonization by Fusobacterium nucleatum in colorectal cancer: Linking microbial virulence, metastatic progression, and therapy resistance

Authors

  • Sarthak Thakur School of Biosciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India Author

Keywords:

Chemoresistance, colorectal cancer, Fusobacterium nucleatum, immunotherapy, metastasis, microbial biomarkers, targeted therapy, tumor microenvironment

Abstract

Colorectal cancer (CRC) is still a major challenge to global health, the bad clinical results being due to tumor progression, metastasis and resistance to anti-cancer treatments.There is growing evidence to show that Fusobacterium nucleatum, an anaerobic bacterium found in the mouth, plays a role in the development and progression of CRC as a result of its interactions with cancer cells, the immune system and the surrounding microbial environment. This review looks at the role of F. nucleatum in the process of colorectal carcinogenesis, in tumor colonization, in the remodeling of the microenvironment, in metastatic spread and in therapeutic resistance, as well as assessing its possible clinical applications and the current limitations of research. The bacterium can affect oncogenic signaling via the FadA–E-cadherin/β-catenin pathway, help immune evasion by interacting with inhibitory immune receptors through Fap2, and modify the inflammatory and immune-cell responses in the tumor microenvironment. Experimental evidence also associates F. nucleatum with metastatic progression via alterations in cellular signaling and the immune environment of the liver. Moreover, it is suggested that the bacterium may lead to chemoresistance by inhibiting apoptosis, pyroptosis and ferroptosis, while its bacterial metabolites can weaken anti-tumor immunity and decrease the sensitivity of tumors to immune checkpoint blockade. Future research needs to combine strain-resolved microbial analysis, carry out longitudinal clinical studies, use improved experimental models and adopt standardized diagnostic methods. A more in-depth understanding of the interactions between host and microbe could eventually lead to the development of reliable biomarkers and targeted therapeutic strategies for CRC associated with F. nucleatum.

0 0

Downloads

Published

2026-09-28